<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Fludarabine and cladribine are <z:chebi fb="0" ids="35584">purine</z:chebi> analogues used to treat <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematological malignancies</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Alone or in combination with therapeutic antibodies, they are effective in treating patients with <z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo> and non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>However, the mechanisms of action of these drugs are not well understood </plain></SENT>
<SENT sid="3" pm="."><plain>Plasma membrane proteins perform a variety of essential functions that can be affected by <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> and perturbed by chemotherapy </plain></SENT>
<SENT sid="4" pm="."><plain>Analysis of surface proteins may contribute to an understanding of the mechanisms of action of <z:chebi fb="0" ids="35584">purine</z:chebi> analogues and identify biomarkers for targeted therapy </plain></SENT>
<SENT sid="5" pm="."><plain>The surface of human cells is rich in N-linked <z:chebi fb="0" ids="17089">glycoproteins</z:chebi>, enabling use of a <z:chebi fb="0" ids="35362">hydrazide</z:chebi>-coupling technique to enrich for <z:chebi fb="0" ids="17089">glycoproteins</z:chebi>, with iTRAQ labeling for quantitative comparison </plain></SENT>
<SENT sid="6" pm="."><plain>A number of plasma membrane proteins on human <z:hpo ids='HP_0001909'>leukemia</z:hpo> and <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells were affected by treatment with a <z:chebi fb="0" ids="35584">purine</z:chebi> analogue, including decreases in CD22 (an <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> and signaling molecule) and increases in CD205 (a "damaged cell marker") and CD80 and CD50 (T-cell interaction molecules) </plain></SENT>
<SENT sid="7" pm="."><plain><z:chebi fb="0" ids="35584">Purine</z:chebi> analogues may affect B-cell receptor (BCR) signaling and costimulatory molecules, leading to multiple signals for <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and cell clearance </plain></SENT>
<SENT sid="8" pm="."><plain>Fludarabine and cladribine induce differential effects, with some cell survival proteins (ECE-1 and CD100) more abundant after fludarabine treatment </plain></SENT>
<SENT sid="9" pm="."><plain>Cell surface proteins induced by fludarabine and cladribine may be targets for therapeutic antibodies </plain></SENT>
</text></document>